A Realworld Study of Acute Respiratory Distress Syndrome in China

NCT02975908 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2016-11-29

No results posted yet for this study

Summary

ARDS is a critical respiratory disease caused by endogenous and exogenous factors. The mortality of ARDS varies from 30 to 70%. In 2012, a new international diagnostic criterion has been put forward. Yet, its feasibility, reliability and validity need to be tested. Meanwhile, the correlation of different severity and prognosis remains unclear. As so far, the epidemiological information about ARDS in China is lacking.

Investigators plan to conduct a multi-center observational study(real-life study) to investigate the risk factors, morbidity, management and prognosis of ARDS in China, in order to facilitate standardization of diagnosis and management of ARDS and provide basic data and idea for further clinical intervention studies.

Conditions

  • Acute Respiratory Distress Syndrome

Sponsors & Collaborators

  • PLA General Hospital

    collaborator UNKNOWN
  • Xiangya No.2 Hospital of Central South University

    collaborator UNKNOWN
  • Xiangya No.1 Hospital of Central South University

    collaborator UNKNOWN
  • The Second Affiliated Hospital of Chongqing Medical University

    collaborator OTHER
  • Beijing Chao Yang Hospital

    collaborator OTHER
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • First Hospital Affiliated to China Medical University

    collaborator UNKNOWN
  • Nanjing General Hospital

    collaborator UNKNOWN
  • Peking University First Hospital

    collaborator OTHER
  • Third Hospital Affiliated to Neimenggu Medical University

    collaborator UNKNOWN
  • Second Hospital Affiliated to Hebei Medical University

    collaborator UNKNOWN
  • Qilu Hospital of Shandong University

    collaborator OTHER
  • First Hospital Affiliated to Anhui Medical University

    collaborator UNKNOWN
  • Ruijin Hospital

    collaborator OTHER
  • Beijing Hospital

    collaborator OTHER_GOV
  • Peking Union Medical College Hospital

    collaborator OTHER
  • No.3 Hospital of Peking University

    collaborator UNKNOWN
  • Fuxing Hospital

    collaborator UNKNOWN
  • Fujian Provincial Hospital

    collaborator OTHER
  • China-Japan Friendship Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2018-02-28
Completion
2019-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02975908 on ClinicalTrials.gov